CenterBook Partners’s Patterson-UTI PTEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-93,213
Closed -$483K 661
2025
Q3
$483K Sell
93,213
-111,705
-55% -$642K 0.02% 488
2025
Q2
$1.22M Sell
204,918
-219,111
-52% -$1.32M 0.07% 308
2025
Q1
$3.49M Buy
+424,029
New +$3.56M 0.22% 125
2022
Q3
Sell
-29,842
Closed -$470K 434
2022
Q2
$470K Buy
+29,842
New +$501K 0.1% 278
2022
Q1
Sell
-53,885
Closed -$455K 372
2021
Q4
$455K Buy
+53,885
New +$464K 0.27% 155

Other funds holding PTEN

CenterBook Partners's PTEN Position: Q4 2025 in Review

CenterBook Partners sold out of Patterson-UTI (PTEN) in Q4 2025, closing a stake of 93,213 shares — an estimated $483K sold.

CenterBook Partners first reported a position in PTEN in Q4 2021 and held it in 5 quarters. The position peaked at $3.49M in Q1 2025. 373 funds tracked by Wall St. Rank hold PTEN as of Q4 2025.

  • CenterBook Partners reported no remaining Patterson-UTI position as of Q4 2025 after selling out during the quarter.
  • CenterBook Partners sold 93,213 Patterson-UTI shares in Q4 2025, an estimated $483K.
  • CenterBook Partners first reported a position in Patterson-UTI in Q4 2021 and held it in 5 quarters.
  • CenterBook Partners's Patterson-UTI position peaked at $3.49M in Q1 2025.
  • 373 funds tracked by Wall St. Rank held Patterson-UTI as of Q4 2025.

Based on CenterBook Partners's 13F filing for Q4 2025, filed 11 Feb 2026.